Robert Harrington to Coronary Restenosis
This is a "connection" page, showing publications Robert Harrington has written about Coronary Restenosis.
Connection Strength
0.426
-
Should we routinely supplement coronary patients with folate therapy to prevent in-stent restenosis? Am Heart J. 2005 Jun; 149(6):1035-6.
Score: 0.244
-
Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft. Circulation. 2006 Jul 04; 114(1 Suppl):I396-401.
Score: 0.066
-
Glycoprotein IIb/IIIa receptor antagonists: a comparative review of their use in percutaneous coronary intervention. Am J Cardiovasc Drugs. 2003; 3(6):423-36.
Score: 0.052
-
Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial. Circulation. 2016 Jan 12; 133(2):131-8.
Score: 0.032
-
Outcomes of second revascularization procedures after stent implantation. J Med Syst. 2008 Apr; 32(2):177-86.
Score: 0.019
-
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep; 126(3 Suppl):576S-599S.
Score: 0.014